Coronado Research

Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer

24 October 2024 -- London, UK -- Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer. Jennifer brings with her a broad portfolio of scientific achievement across academia and industry. She has significant experience of leading research teams in the Clinical Research space and remains at the forefront of...

Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice

3 October 2024 -- London, UK -- Coronado Research announced the engagement of Rob Nichols to support the build-out of its clinical technology practice and advise the executive leadership team as they deliver the broader company vision. He brings significant experience to the table, having worked for IQVIA and Phase Forward during a period of...

Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

10 September 2024 – London, UK Coronado Research is a consultancy-led, professional services organisation operating in the clinical development arena. The company will help pharmaceutical and biotechnology companies optimise their drug development programs by maximising the use of data and technology, and by joining the dots from Regulatory Strategy to Market Access. MacGarvey said, “I am...